QA: TG Therapeutics INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001001316_2017_TG_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001001316, TG Therapeutics INC

  xvar xval
0 AssetsCurrent 50,864,144
1 IntangibleAssetsNetIncludingGoodwill 799,391
2 PropertyPlantAndEquipmentNet 328,148
3 remainder_Assets 2,789,864
4 LiabilitiesCurrent 16,878,440
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,035,305
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,926,550
9 ResearchAndDevelopmentExpense 77,671,287
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,017,272
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 54,781,547
1 Liabilities 18,913,745
2 Expenses 87,597,837
3 Revenues 0
4 StockholdersEquity 35,867,802
5 NetIncome -86,580,565
6 ComprehensiveNetIncome -86,580,565
7 BaseVar 81,155,200
8 EconomicCapitalRatiobeforeLimitedLiability -0.228
9 EconomicCapitalRatio 1.40

Edgar->Model Mapping

Feature Distribution

Change over Time